(1-(Aminomethyl)cyclopentyl)methanol, 95.0%, 250mg

(1-Methyl-4-oxo-1,4-dihydro-pyrazolo[3,4-d]pyrimidin-5-yl)-acetic acid, 250mg

3,5-Dichloro-2,4-difluoroaniline, 95.0%, 25g

2-METHYL-2H-INDAZOLE-4-CARBOXALDEHYDE, 95.0%, 1g

2-Chloro-4-hydrazinylbenzoic acid hydrochloride, 95.0%, 250mg

Boc-R-3-amino-4-(4-tert-butylphenyl)-butyric acid, 97%, 1g

Methyl 4-amino-5-methylthiophene-2-carboxylate, 97%, 100mg

3-Fluoro-5-methoxybenzoic acid, 95.0%, 100g

5-Bromo-2(trifluoromethyl)pyridine, 98.00%, 5g

Microliter syringe GASTIGHT® series 1700 Point type 3, 250 µl, 1725 RNR, 1 piece

(2,2-Dimethyl-5-nitro-1,3-dioxan-5-yl)methanol, 95%, 500mg

Furan-2-boronic acid, 98.0%, 100g

(2E)-3-(3-ethoxyphenyl)acrylic acid, 5g